Cargando…

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia

Detalles Bibliográficos
Autor principal: Davidson, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486198/
https://www.ncbi.nlm.nih.gov/pubmed/26137571
http://dx.doi.org/10.1016/j.ebiom.2015.03.004
_version_ 1782378872948391936
author Davidson, Michael H.
author_facet Davidson, Michael H.
author_sort Davidson, Michael H.
collection PubMed
description
format Online
Article
Text
id pubmed-4486198
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44861982015-07-01 Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia Davidson, Michael H. EBioMedicine Commentary Elsevier 2015-03-09 /pmc/articles/PMC4486198/ /pubmed/26137571 http://dx.doi.org/10.1016/j.ebiom.2015.03.004 Text en © 2015 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Davidson, Michael H.
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_full Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_fullStr Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_full_unstemmed Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_short Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_sort beta-2 agonism: a potential therapeutic target for dyslipidemia
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486198/
https://www.ncbi.nlm.nih.gov/pubmed/26137571
http://dx.doi.org/10.1016/j.ebiom.2015.03.004
work_keys_str_mv AT davidsonmichaelh beta2agonismapotentialtherapeutictargetfordyslipidemia